Travere Therapeutics (TVTX) Treasury Shares (2013 - 2025)
Travere Therapeutics posted quarterly Treasury Shares of $233604.0 for Q4 2025, down 93.36% year-on-year from $3.5 million in Q4 2024, and down 93.36% on a QoQ basis from $3.5 million in Q4 2024.
Travere Therapeutics (TVTX) has 13 years of Treasury Shares data on file, last reported at $233604.0 in Q4 2025.
- For the quarter ending Q4 2014, Treasury Shares rose 235.85% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2014 stood at $3.2 million (up 235.85% YoY), and the FY2014 full-year result was $3.2 million, up 235.85% from the prior year.
- Treasury Shares for Q4 2014 stood at $3.2 million, roughly flat from $3.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.2 million in Q4 2014 and bottomed at $957272.0 in Q4 2013.
- The 5-year median for Treasury Shares is $1.5 million (2021), against an average of $1.7 million.
- The widest annual swing landed in 2023, when Treasury Shares jumped 1730.04%; it then sank 93.36% in 2025.
- A 2-year view of Treasury Shares shows it stood at $957272.0 in 2013, then soared by 235.85% to $3.2 million in 2014.
- The last three Treasury Shares figures came in at $3.2 million (Q4 2014), $3.2 million (Q3 2014), and $957272.0 (Q4 2013), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 233,604.00 |
| Dec 31, 2025 | 233,604.00 |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Dec 31, 2022 | 157,048.00 |
| Dec 31, 2022 | 157,048.00 |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 1.11 Mn |
| Dec 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 233,500.00 |
| Dec 31, 2019 | 233,500.00 |
| Dec 31, 2018 | 400,426.00 |
| Dec 31, 2018 | 400,426.00 |
| Dec 31, 2017 | 250,500.00 |
| Dec 31, 2017 | 250,500.00 |
| Dec 31, 2016 | 407,746.00 |
| Dec 31, 2016 | 407,746.00 |
| Dec 31, 2015 | 429,666.00 |
| Dec 31, 2015 | 429,666.00 |
| Dec 31, 2014 | 3.22 Mn |
| Dec 31, 2014 | 691,668.00 |
| Dec 31, 2014 | 691,668.00 |
| Dec 31, 2014 | 3.22 Mn |
| Sep 30, 2014 | 3.21 Mn |
| Sep 30, 2014 | 614,251.00 |
| Sep 30, 2014 | 614,251.00 |
| Sep 30, 2014 | 3.21 Mn |
| Jun 30, 2014 | 704,657.00 |
| Jun 30, 2014 | 704,657.00 |
| Mar 31, 2014 | 533,395.00 |
| Mar 31, 2014 | 533,395.00 |
| Dec 31, 2013 | 957,272.00 |
| Dec 31, 2013 | 130,790.00 |
| Dec 31, 2013 | 130,790.00 |
| Dec 31, 2013 | 957,272.00 |
| Sep 30, 2013 | 211,072.00 |
| Sep 30, 2013 | 211,072.00 |
| Jun 30, 2013 | 231,493.00 |
| Jun 30, 2013 | 231,493.00 |
| Mar 31, 2013 | 140,673.00 |
| Mar 31, 2013 | 140,673.00 |